HIP ATTACK-2 is a multi-center, international, randomized controlled trial to determine whether accelerated surgery for hip fracture in patients with acute myocardial injury is superior to standard care in reducing death at 90 days after randomization. Other outcomes include; inability to walk 3 meters independently, time to standing and weight-bearing, delirium, length of stay, pain, and quality of life.
Articles
August 7, 2024
Understand heart attack signs, symptoms, and prevention. Discover risk factors and learn what to do during a heart attack from the team at Tufts Medicine.